iTRAQ‐based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

Abstract

Our data suggest a set of serum biomarkers, especially IGFALS, capable of differentiating allergic from nonallergic asthma. These proteins reveal different pathophysiological mechanisms and may be useful in the future for diagnosis, prognosis or targeted therapy purposes.